Ascendis shows combination therapy benefits in achondroplasia trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. GOOGL
6. APGE
7. ABBV
8. USO
9. MSFT
10. IBM

Go back to Ascendis shows combination therapy benefits in achondroplasia trial
Asianada, Inc. (NASDAQ: ASND) Delayed: 228.00 --0 (-0%)
Previous Close $228.00    52 Week High $21.79 
Open $228.00    52 Week Low $11.92 
Day High $228.00    P/E N/A 
Day Low $228.00    EPS $-0.07 
Volume 260